Avatrombopag as a novel salvage therapy for refractory thrombocytopenia in THPO-mutated congenital amegakaryocytic thrombocytopenia after allogeneic hematopoietic stem cell transplantation

Not available.

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-09-17
DOI
https://doi.org/10.3324/haematol.2026.301304
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Avatrombopag as a novel salvage therapy for refractory thrombocytopenia in THPO-mutated congenital amegakaryocytic thrombocytopenia after allogeneic hematopoietic stem cell transplantation

Yuan Cheng-lu, HaiTong Hao, Zi-Jing Ye, Jun Du et al.
Haematologica
Platelet Disorders and Treatments
article

Avatrombopag as a novel salvage therapy for refractory thrombocytopenia in THPO-mutated congenital amegakaryocytic thrombocytopenia after allogeneic hematopoietic stem cell transplantation

Yuan Cheng-lu, HaiTong Hao, Zi-Jing Ye, Jun Du, Ji-Mo Jian
article en

Abstract

No abstract available for this paper.

Haematologica
Shanghai Jiao Tong University (CN), Renji Hospital (CN), Qilu Hospital of Shandong University (CN)
Natural Science Foundation of Shandong Province
Zero hunger
Openalex Percentile: Top 10%
Platelet Disorders and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.